Company Filing History:
3 out of 34 
1 out of 1 
1 out of 1 Years Active: 2011-2017
Title: The Innovations of Hongmin Liu
Introduction
Hongmin Liu is a notable inventor based in Zhengzhou, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of treatments for liver protection and hepatitis C virus.
Latest Patents
Hongmin Liu holds four patents, with his latest innovations focusing on the use of 15-benzylidene-14-deoxy-11, 12-dehydroandrographolide derivatives. These patents disclose the use of andrographolide derivatives in the manufacture of medicaments aimed at protecting the liver and combating the hepatitis C virus. His work emphasizes the prevention and treatment of immunological liver damage caused by viral infections and various chemical liver injuries.
Career Highlights
Throughout his career, Hongmin Liu has been associated with Zhengzhou University, where he has contributed to research and development in medicinal applications. His work has garnered attention for its potential impact on public health, particularly in the treatment of liver-related diseases.
Collaborations
Hongmin Liu has collaborated with notable colleagues, including Guifu Dai and Haiwei Xu. Their joint efforts have further advanced the research in the field of liver protection and antiviral treatments.
Conclusion
Hongmin Liu's innovative work in the field of medicinal chemistry highlights his commitment to improving health outcomes through scientific research. His contributions, particularly in the area of liver protection and hepatitis C treatment, underscore the importance of continued innovation in medicine.